Key result
Endothelial function and arterial stiffness drive HF progression and represent key targets for new therapies.
Why the study?
Outcomes for heart failure patients remain suboptimal with no known therapy improving mortality in acute HF and HF with preserved ejection fraction, necessitating better understanding of vascular function in HF pathophysiology.
Answers are grounded in this paper and cite their sources.
Clinical review highlights vascular mechanisms in heart failure, suggesting endothelial function and arterial stiffness as critical therapeutic targets.
Outcomes for heart failure (HF) patients remain suboptimal. No known therapy improves mortality in acute HF and HF with preserved ejection fraction; the most recent HF trial results have been negative or neutral. Improvement in surrogate markers has not necessarily translated into better outcomes. To translate breakthroughs with potential therapies into clinical benefit, a better understanding of the pathophysiology establishing the foundation of benefit is necessary. Vascular function plays a central role in the development and progression of HF. Endothelial function and nitric oxide availability affect myocardial function, systemic and pulmonary hemodynamics, and coronary and renal circulation. Arterial stiffness modulates ventricular loading conditions and diastolic function, key components of HF with preserved ejection. Endothelial function and arterial stiffness may therefore serve as important physiological targets for new HF therapies and facilitate patient selection for improved application of existing agents.
No takes yet. Share an insight, caveat, or question.
Marti et al. (2012) conducted a review in Heart failure. Endothelial function and arterial stiffness was evaluated. Endothelial function and arterial stiffness play a central role in heart failure progression and may serve as important physiological targets for new therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: